The Executive Guide to Telehealth & Virtual Care in 2026
A working brief for leaders evaluating telehealth & virtual care investments: evidence, market reality, and the questions that matter.
Every technology budget tells a story, and in telehealth & virtual care the 2026 story is one of consolidation, evidence, and reimbursement finally catching up with capability. This guide distills what we hear from operators and what the data shows into a working brief for executives.
Start with the problem, not the product
The costliest failures in this category share a root cause: technology purchased before the workflow, staffing, and payment model to absorb it existed. The discipline that separates successful programs is unglamorous - governance first, a narrowly scoped pilot second, measurement third, and scale only when the first three hold.
The market reality
Consider the current numbers: telehealth utilization jumped 10.1% in a single quarter and now represents 5.51% of all US medical claim lines, per FAIR Health (our coverage).
Meanwhile, medicare telehealth flexibilities run through December 31, 2027, and the hospital-at-home waiver through 2030 (our coverage).
Meanwhile, nearly 400 hospitals are CMS-approved to deliver acute hospital care at home (our coverage).
Meanwhile, teladoc consolidated its 100-million-visit platform into a single integrated care model this summer (our coverage).
Questions to ask every vendor
Where is the peer-reviewed or real-world evidence, and on a population like ours? What happens to our data - who trains on it, who profits from it? What does integration actually require from our EHR team? And what is the exit: if we terminate, what do we keep? Vendors comfortable with these questions tend to be the ones still standing in three years.
The bottom line
Telehealth & Virtual Care rewards patient, evidence-driven adopters. Track the category daily on our Telehealth & Virtual Care page and the topic feeds beneath it.